Skip to main content Accessibility help
  • Print publication year: 2009
  • Online publication date: July 2010

Chapter 21 - Endogenous testosterone levels and cognitive aging in men

from Section 5 - Testosterone, estradiol and men, and sex hormone binding globulin


Editors' introduction

In this chapter, Moffat reviews observational research in older men that examines serum testosterone concentrations in relation to cognitive aging or Alzheimer's disease (AD) risk. Prospective cohort studies, such as the Baltimore Longitudinal Study of Aging, provide particularly useful data. Despite methodological limitations and conflicting findings, Moffat tentatively concludes that age-associated reductions in testosterone concentrations are a risk factor for cognitive decline and dementia. Cognitive vulnerability may be limited to specific domains of cognitive performance and may be modified by apolipoprotein E genotype. As he suggests, more definitive answers may require well designed randomized clinical trials that target cognitive effects of testosterone therapy. Any future trial must also consider other health outcomes that may be beneficially or adversely affected by testosterone.

Related content

Powered by UNSILO


1. Becker JB, Breedlove SM, Crews D. Behavioral Endocrinology. Cambridge, MA: MIT Press.
2. Kerr JE, Allore RJ, Beck SG, Handa RJ. Distribution and hormonal regulation of androgen receptor (AR) and AR messenger ribonucleic acid in the rat hippocampus. Endocrinology. 1995;136(8):3213–21.
3. Roof RL, Havens MD. Testosterone improves maze performance and induces development of a male hippocampus in females. Brain Res. 1992;572(1/2): 310–13.
4. Williams CL, Meck WH. The organizational effects of gonadal steroids on sexually dimorphic spatial ability. Psychoneuroendocrinology. 1991;16(1/3):155–76.
5. Jacobson CD, Csernus VJ, Shryne JE, Gorski RA. The influence of gonadectomy, androgen exposure, or a gonadal graft in the neonatal rat on the volume of the sexually dimorphic nucleus of the preoptic area. J Neurosci. 1981;1(10): 1142–7.
6. Diamond MC. Hormonal effects on the development of cerebral lateralization. Psychoneuroendocrinology. 1991;16(1–3):121–9.
7. Flood JF, Farr SA, Kaiser FE, La Regina M, Morley JE. Age-related decrease of plasma testosterone in SAMP8 mice: replacement improves age-related impairment of learning and memory. Physiol Behav. 1995;57(4):669–73.
8. Pouliot WA, Handa RJ, Beck SG. Androgen modulates N-methyl-D-aspartate-mediated depolarization in CA1 hippocampal pyramidal cells. Synapse. 1996;23(1):10–19.
9. Morse JK, DeKosky ST, Scheff SW. Neurotrophic effects of steroids on lesion-induced growth in the hippocampus. II. Hormone replacement. Exp Neurol. 1992;118(1):47–52.
10. Tirassa P, Thiblin I, Agren G, et al. High-dose anabolic androgenic steroids modulate concentrations of nerve growth factor and expression of its low affinity receptor (p75-NGFr) in male rat brain. J Neurosci Res. 1997;47(2):198–207.
11. Gouras GK, Xu H, Gross RS, et al. Testosterone reduces neuronal secretion of Alzheimer's beta-amyloid peptides. Proc Natl Acad Sci USA. 2000;97(3):1202–5.
12. Pike CJ. Testosterone attenuates beta-amyloid toxicity in cultured hippocampal neurons. Brain Res. 2001;919(1):160–5.
13. Rosario ER, Carroll JC, Oddo S, LaFerla FM, Pike CJ. Androgens regulate the development of neuropathology in a triple transgenic mouse model of Alzheimer's disease. J Neurosci. 2006;26(51): 13384–9.
14. Hammond J, Le Q, Goodyer C, et al. Testosterone-mediated neuroprotection through the androgen receptor in human primary neurons. J Neurochem. 2001;77(5):1319–26.
15. Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab. 2001;86(2):724–31.
16. Lamberts SW, van den Beld AW, van der Lely AJ. The endocrinology of aging. Science. 1997;278(5337): 419–24.
17. Carruthers M. Androgen Deficiency in the Adult Male. London, UK: Taylor & Francis.
18. Gruenewald DA, Matsumoto AM. Testosterone supplementation therapy for older men: potential benefits and risks. J Am Geriatr Soc. 2003;51(1):101–15; discussion 115.
19. Tan RS. Memory loss as a reported symptom of andropause. Arch Androl. 2001;47(3): 185–9.
20. Christiansen K, Knussmann R.. Sex hormones and cognitive functioning in men. Neuropsychobiology. 1987;18(1):27–36.
21. Gouchie C, Kimura D. The relationship between testosterone levels and cognitive ability patterns. Psychoneuroendocrinology. 1991;16(4):323–34.
22. Moffat SD, Hampson E. A curvilinear relationship between testosterone and spatial cognition in humans: possible influence of hand preference. Psychoneuroendocrinology. 1996;21(3):323–37.
23. Aleman A, de Vries WR, Koppeschaar HP, et al. Relationship between circulating levels of sex hormones and insulin-like growth factor-1 and fluid intelligence in older men. Exp Aging Res. 2001;27(3): 283–91.
24. Barrett-Connor E, Goodman-Gruen D, Patay B. Endogenous sex hormones and cognitive function in older men. J Clin Endocrinol Metab. 1999;84(10): 3681–5.
25. Burkhardt MS, Foster JK, Clarnette RM, et al.Interaction between testosterone and apolipoprotein E epsilon4 status on cognition in healthy older men. J Clin Endocrinol Metab. 2006;91(3):1168–72.
26. Driscoll I, Hamilton DA, Yeo RA, Brooks WM, Sutherland RJ. Virtual navigation in humans: the impact of age, sex, and hormones on place learning. Horm Behav. 2005;47(3):326–35.
27. Fonda SJ, Bertrand R, O'Donnell A, Longcope C, McKinlay JB. Age, hormones, and cognitive functioning among middle-aged and elderly men: cross-sectional evidence from the Massachusetts Male Aging Study. J Gerontol A Biol Sci Med Sci. 2005;60(3):385–90.
28. Geerlings MI, Strozyk D, Masaki K, et al. Endogenous sex hormones, cognitive decline, and future dementia in old men. Ann Neurol. 2006;60(3):346–55.
29. Hogervorst E, De Jager C, Budge M, Smith AD. Serum levels of estradiol and testosterone and performance in different cognitive domains in healthy elderly men and women. Psychoneuroendocrinology. 2004;29(3):405–21.
30. Martin DM, Wittert G, Burns NR, Haren MT, Sugarman R. Testosterone and cognitive function in ageing men: data from the Florey Adelaide Male Ageing Study (FAMAS). Maturitas. 2007;57(2):182–94.
31. Moffat SD, Zonderman AB, Metter EJ, et al. Longitudinal assessment of serum free testosterone concentration predicts memory performance and cognitive status in elderly men. J Clin Endocrinol Metab. 2002;87(11):5001–7.
32. Morley JE, Kaiser F, Raum WJ, et al. Potentially predictive and manipulable blood serum correlates of aging in the healthy human male: progressive decreases in bioavailable testosterone, dehydroepiandrosterone sulfate, and the ratio of insulin-like growth factor 1 to growth hormone. Proc Natl Acad Sci USA. 1997;94(14):7537–42.
33. Muller M, Aleman A, Grobbee DE, de Haan EH, van der Schouw YT. Endogenous sex hormone levels and cognitive function in aging men: is there an optimal level? Neurology. 2005;64(5):866–71.
34. Perry PJ, Lund BC, Arndt S, et al. Bioavailable testosterone as a correlate of cognition, psychological status, quality of life, and sexual function in aging males: implications for testosterone replacement therapy. Ann Clin Psychiatry. 2001;13(2):75–80.
35. Thilers PP, Macdonald SW, Herlitz A. The association between endogenous free testosterone and cognitive performance: a population-based study in 35 to 90 year-old men and women. Psychoneuroendocrinology. 2006;31(5):565–76.
36. Wolf OT, Kirschbaum C. Endogenous estradiol and testosterone levels are associated with cognitive performance in older women and men. Horm Behav. 2002;41(3):259–66.
37. Yaffe K, Lui LY, Zmuda J, Cauley J. Sex hormones and cognitive function in older men. J Am Geriatr Soc. 2002;50(4):707–12.
38. Yeap BB, Almeida OP, Hyde Z, et al. Higher serum free testosterone is associated with better cognitive function in older men, while total testosterone is not. The Health in Men Study. Clin Endocrinol (Oxf). 2008;68(3):404–12.
39. Brinton RD. Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action. Ann N Y Acad Sci. 2005;1052:57–74.
40. Sherwin BB. Estrogen and memory in women: how can we reconcile the findings? Horm Behav. 2005;47(3):371–5.
41. Guazzo EP, Kirkpatrick PJ, Goodyer IM, Shiers HM, Herbert J. Cortisol, dehydroepiandrosterone (DHEA), and DHEA sulfate in the cerebrospinal fluid of man: relation to blood levels and the effects of age. J Clin Endocrinol Metab. 1996;81(11):3951–60.
42. Mulchahey JJ, Ekhator NN, Zhang H, et al. Cerebrospinal fluid and plasma testosterone levels in post-traumatic stress disorder and tobacco dependence. Psychoneuroendocrinology. 2001;26(3):273–85.
43. Moffat SD, Zonderman AB, Metter EJ, et al. Free testosterone and risk for Alzheimer disease in older men. Neurology. 2004;62(2):188–93.
44. Bowen RL, Isley JP, Atkinson RL. An association of elevated serum gonadotropin concentrations and Alzheimer disease. J Neuroendocrinol. 2000;12(4):351–354.
45. Hogervorst E, Williams J, Budge M, et al. Serum total testosterone is lower in men with Alzheimer's disease. Neuroendocrinol Lett. 2001;22(3):163–8.
46. Paoletti AM, Congia S, Lello S, et al. Low androgenization index in elderly women and elderly men with Alzheimer's disease. Neurology. 2004;62(2):301–3.
47. Watanabe T, Koba S, Kawamura M, et al. Small dense low-density lipoprotein and carotid atherosclerosis in relation to vascular dementia. Metabolism. 2004;53(4):476–82.
48. Ravaglia G, Forti P, Maioli F, et al. Endogenous sex hormones as risk factors for dementia in elderly men and women. J Gerontol A Biol Sci Med Sci. 2007;62(9):1035–41.
49. Pennanen C, Laakso MP, Kivipelto M, Ramberg J, Soininen H. Serum testosterone levels in males with Alzheimer's disease. J Neuroendocrinol. 2004;16(2):95–8.
50. Rosario ER, Chang L, Stanczyk FZ, Pike CJ. Age-related testosterone depletion and the development of Alzheimer disease. JAMA. 2004;292(12):1431–2.
51. Hogervorst E, Bandelow S, Combrinck M, Smith AD. Low free testosterone is an independent risk factor for Alzheimer's disease. Exp Gerontol. 2004;39(11/12): 1633–9.
52. Rasmuson S, Nasman B, Carlstrom K, Olsson T. Increased levels of adrenocortical and gonadal hormones in mild to moderate Alzheimer's disease. Dement Geriatr Cogn Disord. 2002;13(2):74–9.
53. Chu LW, Tam S, Lee PW, et al. Bioavailable testosterone is associated with a reduced risk of amnestic mild cognitive impairment in older men. Clin Endocrinol (Oxf). 2008;68(4):589–98.
54. Hogervorst E, Bandelow S. The controversy over levels of sex steroids in cases with Alzheimer's disease. J Neuroendocrinol. 2004;16(2):93–4.
55. Meethal SV, Smith MA, Bowen RL, Atwood CS. The gonadotropin connection in Alzheimer's disease. Endocrine. 2005;26(3):317–26.
56. Bowen RL, Smith MA, Harris PL, et al. Elevated luteinizing hormone expression colocalizes with neurons vulnerable to Alzheimer's disease pathology. J Neurosci Res. 2002;70(3):514–18.